Showing results (1-10 of 409) with videos related to
Sort By:
Pageof 41
Biological Psychiatry|November 3, 1998
Relationship between patient variables and plasma clozapine concentrations: a dosing nomogramP J Perry, K A Bever, S Arndt, et al.Pharmacotherapy|December 17, 1997
N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopeniaM D Combs, P J Perry, K A BeverAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 1997
Dexfenfluramine hydrochloride: an anorexigenic agentK A Bever, P J PerryAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 2, 1998
Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapyK A Bever, P J PerryAnnals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|September 6, 2001
Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapyP J Perry, B C Lund, S Arndt, et al.Pharmacotherapy|August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly menB C Lund, K A Bever-Stille, P J PerryJournal of Clinical Psychopharmacology|August 1, 1994
Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of responseP J Perry, C Zeilmann, S ArndtAnnals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 17, 2002
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adultsS Kuperman, P J Perry, G R Gaffney, et al.Archives of General Psychiatry|December 26, 2001
Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approachB C Lund, P J Perry, J M Brooks, et al.The American Journal of Drug and Alcohol Abuse|November 21, 1997
The effects of anabolic steroids on driving performance as assessed by the Iowa Driver SimulatorV L Ellingrod, P J Perry, W R Yates, et al.Pageof 41